VIEMED HEALTHCARE, INC. — fact timeline

VIEMED HEALTHCARE, INC. shareholders approved Advisory vote on executive compensation.

“Shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers (the “say-on-pay” vote).”

VIEMED HEALTHCARE, INC. shareholders approved Ratification of Second Amendment to the 2024 LTIP.

“Shareholders approved an ordinary resolution to ratify, confirm, and approve the Second Amendment to the 2024 LTIP.”

VIEMED HEALTHCARE, INC. shareholders approved Appointment of Ernst & Young LLP as independent auditors at the 2026-12-31 meeting.

“Shareholders approved the appointment of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorized the Company's Board of Directors to fix their remuneration.”

VIEMED HEALTHCARE, INC. shareholders approved Election of seven director nominees.

“Shareholders elected each of the seven director nominees to serve until the next annual meeting of shareholders or until their successors are duly elected or appointed.”

VIEMED HEALTHCARE, INC. reported the three months ended March 31, 2026 results: revenue $75.4 million, net income $2.6 million, EPS $0.06 per diluted share. Guidance raised.

“and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025. • Net income attributable to Viemed for the”

Bruce Greenstein resigned as Director at VIEMED HEALTHCARE, INC..

“On April 14, 2025, Bruce Greenstein notified Viemed Healthcare, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective immediately.”

VIEMED HEALTHCARE, INC. reported three months ended March 31, 2024 results: revenue $50.6 million, net income $1.6 million.

“Net revenues for the quarter ended March 31, 2024 were $50.6 million , representing an increase of $11.0 million , or 28% , over net revenues reported for the comparable quarter ended March 31, 2023. • Net income for the quarter ended March 31, 2024 totaled $1.6 million.”

VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2023 results: revenue $50.7 million, net income $3.5 million.

“and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increase of $13.2 million, or 35%, over net revenues reported for the comparable quarter ended December 31, 2022. Total net revenues for the year ended December”